Gene Modification – Page 4

CRISPR Gene Editing Therapy Can Be Administered Twice, Intellia Study Suggests

2 years ago talkbio0Tagged Amyloidosis, Clustered Regularly Interspaced Short Palindromic Repeats, Gene Modification, gene therapy, Intellia, Prealbumin, re-dosing

CRISPR, gene editing, Intellia Therapeutics, transthyretin amyloidosis, gene therapy, re-dosing

Exsilio Therapeutics Launches with $82 Million to Develop mRNA-Based Genomic Medicines Under Tal Zaks’ Leadership

2 years ago talkbio0Tagged Approved, Exsilio, Gene Modification, gene therapy, genomic medicines, Lipids, nanoparticle delivery, RNA, Messenger, safety profile, Tal Zaks

Exsilio Therapeutics, mRNA, genomic medicines, Tal Zaks, gene therapy, gene editing, lipid nanoparticle delivery, redosing, safety profile, gene therapy approval

Intellia Therapeutics Advances in Hereditary Angioedema Treatment with Durable One-Dose CRISPR Gene Editing Therapy

2 years ago talkbio0Tagged Angioedemas, Hereditary, Clinical Trials, Clustered Regularly Interspaced Short Palindromic Repeats, Gene Modification, Intellia, Long-term, single-dose

Intellia Therapeutics, Hereditary Angioedema (HAE), CRISPR Gene Editing, NTLA-2002, Single-Dose Treatment, Long-Term Data, Clinical Trials

Intellia Therapeutics Reports Promising Long-Term Data for Single-Dose HAE Therapy

2 years ago talkbio0Tagged Angioedemas, Hereditary, Clustered Regularly Interspaced Short Palindromic Repeats, Gene Modification, Intellia, Long-term, NTLA-2002, single-dose

Intellia Therapeutics, NTLA-2002, Hereditary Angioedema (HAE), CRISPR Gene Editing, Single-Dose Treatment, Long-Term Data

Preliminary CRISPR-Based HIV Treatment Study Shows Limited Success

2 years ago talkbio0Tagged Clustered Regularly Interspaced Short Palindromic Repeats, curative potential, Gene Modification, HIV, Success

CRISPR, HIV, gene editing, treatment, study, curative potential, early study, limited success

Revival of Gene Editing Clinical Trials in China Post CRISPR Baby Scandal

2 years ago talkbio0Tagged baby scandal, Biotechnology, China, Clinical Trials, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas9, Gene Modification, Hereditary Diseases, regulatory

CRISPR baby scandal, China, gene editing, clinical trials, restart, regulations, ethics, CRISPR-Cas9, genetic diseases, biotechnology.

Moderna Terminates Gene Editing Partnership, Shifts Focus to mRNA Technology

2 years ago talkbio0Tagged biobucks, Biotechnology, deal termination, Gene Modification, Metagenomi, Moderna, mRNA technology, Partnership

Moderna, Metagenomi, gene editing, partnership, mRNA technology, biotechnology, biobucks, deal termination

Prime Medicine Secures FDA Approval for Pioneering Gene Editing Therapy Trial

2 years ago talkbio0Tagged Approved, Clinical Trials, Gene Modification, Hereditary Diseases, Prime Medicine, United States Food and Drug Administration

Prime Medicine, FDA approval, gene editing, clinical trial, innovative therapy, genetic diseases

Regeneron Pharmaceuticals Expands Gene Editing Capabilities with Mammoth Biosciences Partnership

2 years ago talkbio0Tagged Biotechnology, Clustered Regularly Interspaced Short Palindromic Repeats, development aspects, Gene Modification, Genetic Research, Health care facility, Mammoth Biosciences, Partnership, Regeneron

Regeneron, Mammoth Biosciences, gene editing, CRISPR, partnership, biotechnology, healthcare, pharmaceuticals, genetic research, therapeutic development.

Revolutionizing Gene Editing: Regeneron and Mammoth Biosciences’ $100M Partnership

2 years ago talkbio0Tagged Biotechnology, Clustered Regularly Interspaced Short Palindromic Repeats, Collaboration, Gene Modification, healthcare innovation, Mammoth Biosciences, Regeneron

Regeneron, Mammoth Biosciences, CRISPR, gene editing, delivery system, therapeutics, collaboration, biotechnology, healthcare innovation.